These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 31593704

  • 1. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
    Zhang E, Liu J, Shi L, Guo X, Liang Z, Zuo J, Xu H, Wang H, Shu X, Huang S, Zhang S, Kang X, Zhen Y.
    Life Sci; 2019 Dec 01; 238():116938. PubMed ID: 31593704
    [Abstract] [Full Text] [Related]

  • 2. Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of Adriamycin by reserving P-gp-mediated drug resistance in breast cancer.
    Chen Y, Li X, Shi L, Ma P, Wang W, Wu N, Gan Y, Han X, Huang S, Kang X, Liu S, Zhen Y.
    Aging (Albany NY); 2022 Sep 14; 14(17):7156-7169. PubMed ID: 36107024
    [Abstract] [Full Text] [Related]

  • 3. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C, Guan X, Xue H, Wang P, Wang M, Gai X.
    Pathol Res Pract; 2017 Jul 14; 213(7):848-853. PubMed ID: 28554760
    [Abstract] [Full Text] [Related]

  • 4. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.
    Zuo J, Jiang Y, Zhang E, Chen Y, Liang Z, Zhu J, Zhao Y, Xu H, Liu G, Liu J, Wang W, Zhang S, Zhen Y.
    Life Sci; 2019 Jun 15; 227():145-152. PubMed ID: 31009625
    [Abstract] [Full Text] [Related]

  • 5. The reversal effects of 3-bromopyruvate on multidrug resistance in vitro and in vivo derived from human breast MCF-7/ADR cells.
    Wu L, Xu J, Yuan W, Wu B, Wang H, Liu G, Wang X, Du J, Cai S.
    PLoS One; 2014 Jun 15; 9(11):e112132. PubMed ID: 25372840
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X, Chang Z, Song J, Gao G, Shen Z.
    Anticancer Drugs; 2011 Jul 15; 22(6):556-62. PubMed ID: 21637162
    [Abstract] [Full Text] [Related]

  • 7. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.
    Yang L, Zhang C, Chen J, Zhang S, Pan G, Xin Y, Lin L, You Z.
    Pharm Biol; 2020 Dec 15; 58(1):276-285. PubMed ID: 32251615
    [Abstract] [Full Text] [Related]

  • 8. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z.
    Mol Med Rep; 2016 Jun 15; 13(6):4745-50. PubMed ID: 27082231
    [Abstract] [Full Text] [Related]

  • 9. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.
    Lv L, Liu C, Chen C, Yu X, Chen G, Shi Y, Qin F, Ou J, Qiu K, Li G.
    Oncotarget; 2016 May 31; 7(22):32184-99. PubMed ID: 27058756
    [Abstract] [Full Text] [Related]

  • 10. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
    Li Y, Sun Y, Tang T, Niu Y, Li X, Xie M, Jin H, Mei Q.
    J Ethnopharmacol; 2019 Mar 25; 232():47-54. PubMed ID: 30552993
    [Abstract] [Full Text] [Related]

  • 11. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH, Shin YJ, Won AJ, Lee BM, Choi WS, Jung JH, Chung HY, Kim HS.
    Biochim Biophys Acta; 2014 Jan 25; 1840(1):615-25. PubMed ID: 24161697
    [Abstract] [Full Text] [Related]

  • 12. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W, Meng Q, Sun Y, Wang C, Huo X, Liu Z, Sun P, Sun H, Ma X, Liu K.
    Cell Physiol Biochem; 2018 Jan 25; 51(4):1616-1631. PubMed ID: 30497065
    [Abstract] [Full Text] [Related]

  • 13. The tissue transglutaminase: a potential target regulating MDR in breast cancer.
    Cheng K, Wang XH, Hua YT, Zhang YZ, Han Y, Yang ZL.
    Eur Rev Med Pharmacol Sci; 2020 Jun 25; 24(11):6175-6184. PubMed ID: 32572883
    [Abstract] [Full Text] [Related]

  • 14. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells.
    Xiang W, Gao A, Liang H, Li C, Gao J, Wang Q, Shuang B, Zhang J, Yan Y, Wang X.
    Toxicol In Vitro; 2010 Sep 25; 24(6):1474-81. PubMed ID: 20656007
    [Abstract] [Full Text] [Related]

  • 15. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca2+ -mediated apoptosis pathways in MCF-7/ADR and K562/ADR.
    Sun Y, Wang C, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Peng J, Liu K.
    J Cell Physiol; 2018 Apr 25; 233(4):3066-3079. PubMed ID: 28681913
    [Abstract] [Full Text] [Related]

  • 16. [Reversal effect and its mechanism of (- )-5-N-acetylardeemin on adriamycin resistance in multidrug-resistant cancer cells A549/Adr and MCF-7/Adr].
    Zhao C, Zheng XL, Yan YY, Song H, Li DX, Yang L, Qin Y, Lin Y, Wang X, Liao LC.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov 25; 45(6):893-7. PubMed ID: 25571710
    [Abstract] [Full Text] [Related]

  • 17. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin.
    Gao A, Wang X, Xiang W, Liang H, Gao J, Yan Y.
    J Pharm Pharmacol; 2010 Mar 25; 62(3):393-9. PubMed ID: 20487225
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R, Peng H, Yuan X, Zhang X, Zhang Y, Fan D, Liu X, Xiong D.
    J Cell Biochem; 2013 Aug 25; 114(8):1890-900. PubMed ID: 23494858
    [Abstract] [Full Text] [Related]

  • 19. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F, Fan J, Wu Z, Liu RY, Guo L, Dong Z, Wang Z.
    Pharm Biol; 2013 Sep 25; 51(9):1196-203. PubMed ID: 23777360
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells.
    Zhu CY, Lv YP, Yan DF, Gao FL.
    Asian Pac J Cancer Prev; 2013 Sep 25; 14(11):6757-60. PubMed ID: 24377601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.